Use of thiazolidinediones and glucagon-like peptide-1 receptor agonists and the risk of non-alcoholic fatty liver disease

Johanna H. M. Driessen, Judith van Dalem, Andrea M. Burden, Coen D. A. Stehouwer, Olaf H. Klungel, Frank de Vries, Martijn C. G. J. Brouwers

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)128-128
Number of pages1
JournalPharmacoepidemiology and Drug Safety
Volume29
Publication statusPublished - Oct 2020

Cite this